In contrast, significant reduction of BCL2L13 mRNA and exon expression were both found in ccRCC and pRCC primary tumors, when compared to corresponding normal tissues (Fig. 1). The gene discussed is BCL2L13; the disease is nonpapillary renal cell carcinoma.